US Patent Issued to Shenzhen Blood Center on Sept. 23 for "Method and kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS)" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,549, issued on Sept. 23, was assigned to Shenzhen Blood Center (Guangdong, China).

"Method and kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS)" was invented by Shuang Liang (Guangdong, China), Jinfeng Zeng (Guangdong, China), Yanlian Liang (Guangdong, China), Fan Wu (Guangdong, China), Tong Liu (Guangdong, China) and Liyan Sun (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method and a kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS) are provided. Multiplex PCR capture primer sets and amplification reaction ...